We are live on ! Find out more
TC

Trilogy Capital Portfolio holdings

AUM $2.58B
1-Year Est. Return 22.97%
This Fund
S&P 500
This Quarter Est. Return
+9.65%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
AUM
$840M
AUM Growth
+$96.4M
Cap. Flow
+$28.6M
Cap. Flow %
3.41%
Top 10 Hldgs %
49.46%
Holding
166
New
35
Increased
31
Reduced
56
Closed
42

Sector Composition

Rank Sector Weight
1 Consumer Staples 0.79%
2 Consumer Discretionary 0.59%
3 Utilities 0.59%
4 Technology 0.45%
5 Financials 0.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNL icon
51
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$474M
$3.46M 0.41%
+124,156
New +$3.33M
SHY icon
52
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
$3.42M 0.41%
40,678
-10,638
-21% -$891K
BSCM
53
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
$3.37M 0.4%
159,522
+24,569
+18% +$513K
BSCL
54
DELISTED
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
$3.35M 0.4%
159,053
+25,135
+19% +$525K
BSCJ
55
DELISTED
Invesco BulletShares 2019 Corporate Bond ETF
BSCJ
$3.16M 0.38%
149,987
+24,633
+20% +$519K
BSCK
56
DELISTED
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
$3.16M 0.38%
148,836
+23,219
+18% +$491K
PG icon
57
Procter & Gamble
PG
$349B
$2.49M 0.3%
23,888
-3,317
-12% -$323K
SMLF icon
58
iShares US Small Cap Equity Factor ETF
SMLF
$4.07B
$2.07M 0.25%
51,576
-1,702
-3% -$67.5K
VEU icon
59
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$1.14M 0.14%
22,779
-3
-0% -$147
AOR icon
60
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.63B
$1.01M 0.12%
22,554
+1,182
+6% +$51.4K
CAG icon
61
Conagra Brands
CAG
$6.83B
$969K 0.12%
+34,926
New +$801K
AAPL icon
62
Apple
AAPL
$4.9T
$962K 0.11%
20,248
-3,844
-16% -$163K
EIX icon
63
Edison International
EIX
$29.9B
$935K 0.11%
15,093
-598
-4% -$35.7K
GIS icon
64
General Mills
GIS
$20.3B
$918K 0.11%
17,735
+911
+5% +$41.3K
SO icon
65
Southern Company
SO
$107B
$852K 0.1%
16,489
+9,537
+137% +$467K
ETR icon
66
Entergy
ETR
$52.8B
$829K 0.1%
17,330
-5,156
-23% -$233K
CPB icon
67
Campbell Soup
CPB
$6.58B
$808K 0.1%
21,178
+14,556
+220% +$514K
PPL
68
PPL Corp
PPL
$27B
$789K 0.09%
24,845
-3,992
-14% -$124K
CAH icon
69
Cardinal Health
CAH
$53.5B
$747K 0.09%
15,512
+10,911
+237% +$547K
XRX icon
70
Xerox
XRX
$362M
$743K 0.09%
23,241
+3,510
+18% +$99K
BRK.B icon
71
Berkshire Hathaway Class B
BRK.B
$1.06T
$732K 0.09%
3,644
-448
-11% -$90.4K
WU icon
72
Western Union
WU
$2.77B
$722K 0.09%
39,072
+352
+0.9% +$6.33K
WDC icon
73
Western Digital
WDC
$164B
$710K 0.08%
+19,555
New +$669K
T icon
74
AT&T
T
$152B
$709K 0.08%
+29,917
New +$688K
HBI
75
DELISTED
Hanesbrands
HBI
$679K 0.08%
+38,003
New +$631K

Similar funds

Trilogy Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Trilogy Capital held 166 positions worth $840M, up 13% from $743M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Trilogy Capital deployed $28.6M of net new capital in Q1 2019, opening 35 new positions and adding to 31 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 Growth ETF: 179,055 shares worth $6.66M.

By sector, the portfolio is most concentrated in Consumer Staples at 0.79% of assets, down from 1% a quarter earlier, followed by Consumer Discretionary and Utilities.

On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $17.8M trimmed.

  • Trilogy Capital's largest Q1 2019 buy was State Street SPDR Portfolio S&P 500 Growth ETF: 179,055 shares worth $6.66M.
  • Trilogy Capital added most to iShares MSCI USA Quality Factor ETF in Q1 2019, an estimated $26.1M increase.
  • Trilogy Capital's biggest Q1 2019 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $17.8M.
  • Trilogy Capital fully exited Invesco FTSE RAFI US 1000 ETF in Q1 2019, selling an estimated $2.93M.
  • Trilogy Capital's ten largest holdings make up 49% of its $840M portfolio in Q1 2019.
  • Trilogy Capital opened 35 new positions and closed 42 in Q1 2019.
  • Trilogy Capital's portfolio value rose 13% quarter-over-quarter to $840M.

Based on Trilogy Capital's 13F filing for Q1 2019, filed 17 Apr 2019.